Cancer-selective, single agent chemoradiosensitising gold nanoparticles.

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Oncology

Background:

• Gold nanoparticles (AuNPs) are being explored for cancer therapy.
• Targeted delivery and reduced toxicity are key challenges in nanomedicine.

Purpose of the Study:

• To synthesize and evaluate 2nm AuNPs with specific surface modifications for cancer treatment.
• To assess the in vitro chemotoxicity and radiosensitizing potential of these AuNPs.

Main Methods:

• Synthesis of 2nm AuNPs functionalized with sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine).
• In vitro evaluation of AuNP toxicity and radiosensitization across four cell lines (normal and cancerous skin/breast).
• Assessment of chemotoxicity using N-acetyl cysteine and Z-VAD-FMK.

Main Results:

• AuNPs functionalized with PEG-amine or a 50:50 alpha-galactose derivative/PEG-amine ratio exhibited selective uptake and toxicity towards cancer cells at nanomolar concentrations.
• AuNPs demonstrated radiosensitizing effects when combined with 220 kV and 6 MV X-rays.
• Chemotoxicity was mitigated by N-acetyl cysteine and partially by Z-VAD-FMK.

Conclusions:

• Simple ligand-bearing AuNPs can act as cancer-selective chemoradiosensitizers at low concentrations.
• This finding presents a novel approach for developing affordable cancer nanotherapeutics.
• The selective toxicity and radiosensitizing ability of these AuNPs hold significant promise for future cancer treatment strategies.